Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $11.03 million. The enterprise value is -$5.35 million.

Market Cap	11.03M
Enterprise Value	-5.35M

Important Dates

The last earnings date was Friday, May 10, 2024, after market close.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

MBRX has 2.31 million shares outstanding. The number of shares has increased by 28.67% in one year.

Shares Outstanding	2.31M
Shares Change (YoY)	+28.67%
Shares Change (QoQ)	+22.18%
Owned by Insiders (%)	4.65%
Owned by Institutions (%)	15.53%
Float	1.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.51
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.02.

Current Ratio	3.51
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.20% and return on invested capital (ROIC) is -126.85%.

Return on Equity (ROE)	-87.20%
Return on Assets (ROA)	-68.90%
Return on Capital (ROIC)	-126.85%
Revenue Per Employee	n/a
Profits Per Employee	-$1.49M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.40% in the last 52 weeks. The beta is 1.85, so MBRX's price volatility has been higher than the market average.

Beta (1Y)	1.85
52-Week Price Change	-50.40%
50-Day Moving Average	4.98
200-Day Moving Average	7.45
Relative Strength Index (RSI)	42.94
Average Volume (30 Days)	87,985

Short Selling Information

The latest short interest is 34,221, so 1.48% of the outstanding shares have been sold short.

Short Interest	34,221
Short Previous Month	31,100
Short % of Shares Out	1.48%
Short % of Float	1.78%
Short Ratio (days to cover)	1.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.95M
Pretax Income	-26.82M
Net Income	-26.82M
EBITDA	-26.70M
EBIT	-26.82M
Earnings Per Share (EPS)	-$13.04

Full Income Statement

Balance Sheet

The company has $16.82 million in cash and $450,000 in debt, giving a net cash position of $16.37 million or $7.08 per share.

Cash & Cash Equivalents	16.82M
Total Debt	450,000
Net Cash	16.37M
Net Cash Per Share	$7.08
Equity / Book Value	21.59M
Book Value Per Share	9.34
Working Capital	13.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.80 million and capital expenditures -$124,000, giving a free cash flow of -$24.93 million.

Operating Cash Flow	-24.80M
Capital Expenditures	-124,000
Free Cash Flow	-24.93M
FCF Per Share	-$10.11

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.67%
Shareholder Yield	-28.67%
Earnings Yield	-243.28%
FCF Yield	-226.06%

Analyst Forecast

The average price target for MBRX is $35.00, which is 654.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.00
Price Target Difference	654.31%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1